Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma (Q44551425)
scientific article published in March 2004
Language:
(P31) (Q13442814)
(P50) (Q37392552)
(Q90323603)
(P304) 909-918
(P407) (Q1860)
(P433) 5
(P478) 22
(P577) Monday, March 1, 2004
(P921) (Q32089)
(P1433) (Q400292)
(P1476) "Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma" (language: en)
(P2093) Michael B Atkins
Walter M Stadler
Theodore F Logan
Gary R Hudes
Young Park
Song-Heng Liou
Bonnie Marshall
Joseph P Boni
Gary Dukart
Matthew L Sherman
(P2860) (Q56765704)
(Q28217173)
other details
description scientific article published in March 2004

External Links